SlideShare a Scribd company logo
1 of 1
Download to read offline
Effect of Erk1/2 on Muscle Fiber Morphology and Differentiation
Gabrielle Henslee, Bonnie Seaberg, Ximena Paez, Mendell Rimer
Department of Neuroscience & Experimental Therapeutics, Texas A&M Health Science Center College of Medicine, Bryan, TX, USA
Materials and Methods
Fiber-typing: Sternomastoid (STN) and tibialis anterior (TA) muscles from 14-week-old mice (three animals from each of the
four above-mentioned genotypes) were dissected and flash frozen with OCT medium (tissue tek) in an isopentane/liquid N2
bath. 14μm-thick cross-sections were cut in a cryostat and mounted on a slide. Sections were not fixed at any time. Sections
were washed in PBS for 5min, then washed three times in PBS-T for 5min each. The cross sections were blocked in PBS-T +
10% normal goat serum for 20min at room temperature and then incubated overnight in a myosin 2B antibody (undiluted,
DSHB 10F5) or a myosin slow antibody (undiluted, DSHB A4.840) plus dystrophin (1:300, AbCam 15277). After three 15min
washes in PBS-T the following morning, the muscle sections were incubated at room temperature for 2h with a fluorescein-
conjugated goat anti-mouse (1:128) and rhodamine-conjugated goat anti-rabbit (1:400) secondary antibody. After washes in
PBS-T and PBS, slides were mounted using VectaShield. A 10X, 0.3 NA objective (Nikon Eclipse 1000) was used to acquire
widefield images of myofibers with MetaMorph Software, taking as many images needed to encompass the entire area of a
single whole muscle section with overlapping myofibers. The images were then compiled into a single picture. Total fibers were
counted on the dystrophin channel, and unstained fibers were counted on the color merge. The number and percentage of
stained fibers were calculated from these values.
Fiber Area: The dystrophin-stained images for control and Cre+Erk1-/-Erk2f/f from the above-described compilations were
analyzed for myofiber area using the integrated morphometric analysis tool in MetaMorph. Calibrated images were thresholded
for dark objects and manually adjusted to fill the entire interior core surrounded by dystrophin staining for as many myofibers
as possible per image. The entire section was analyzed and myofibers overlapped by multiple images were only analyzed a
single time.
Introduction
Fiber Types: Muscle fibers can be classified into two distinct types. Type 1 fibers, also called slow fibers, are characterized by
small size and great resistance to fatigue due to rich myoglobin content and mitochondria. Type 1 fibers contract slowly and do
not generate much force. Type 2 fibers can be subdivided into three separate categories. Type 2B fibers are generally the
largest in size and can generate a great amount of force, but due to low mitochondrial count, they fatigue easily, and thus are
also known as fast fatigable units. Type 2A units are an intermediary between slow and 2B. They are not as fast as 2B,
generate more force than slow, and are moderately sized. While they fatigue faster than type 1, they have more endurance
than 2B. These characteristics have led to them being known as fast fatigue-resistant units. The third type is designated 2X,
and its characteristics fall midway between 2A and 2B.
Extracellular-signal Regulated Kinase: Extracellular-signal regulated kinase 1 and 2 (Erk1/2) are part of a signaling
cascade involved in many different cellular processes. Erk1/2 can act as an inhibitor or an activator during skeletal muscle
differentiation. It has also been implicated as playing a role in the regulation of fiber type differentiation. However, literature
reports conflicting results regarding the need of Erk1/2 signaling for slow or fast fiber differentiation. Currently no one has fully
investigated the effect of Erk1/2 on fiber type distribution in vivo.
Hypothesis: Elimination of Erk1/2 (separately and concurrently) will affect muscle fiber morphology and development.
Animal Model: The mice used in this study are C57BL/6 background. Erk1 knockouts were generated by inserting a Neo
cassette, resulting in germline Erk1 elimination and are noted as Erk1-/-. Erk2 knockouts were generated conditionally making
use of the Cre/loxP system. Cre excises sequences flanked by loxP sites; in this way, a gene’s elimination can be controlled by
either pharmacologically or constitutively supplying Cre. In this experiment, Cre expression was limited to skeletal muscle
fibers by using a human alpha-skeletal actin (HSA) promoter to drive Cre expression. Erk2 conditional knockouts are noted as
Cre+Erk2f/f. Control animals were Cre- siblings, as Erk2 expression is unchanged in the absence of Cre. Double knockouts
were generated by crossing Erk1-/- and Cre+Erk2f/f animals and backcrossing to reestablish homozygocity. These animals are
noted as Cre+Erk1-/-Erk2f/f.
Conclusions and Future Studies
Area: There is an observed shift in distribution in myofiber area between the control and Cre+Erk1-/-Erk2f/f that, together with
total fiber count, likely contributes to both the smaller muscle size and lower observed weights.
Fast 2B Fibers: The 2B fiber type comprises 50% or more of the total fibers in both STN and TA for all genotypes and are
visually observed to be larger than unstained (non-2B) fibers. No statistical significance was found between the controls and
various mutants.
Slow Fibers: Neither STN nor TA has many slow fibers. In STN there is a slight reduction in slow fibers in all mutant
genotypes as compared to control with significance observed for Erk1-/- only. On the other hand, there is an increase in slow
fibers in all mutant genotypes with significance in Cre+Erk1-/-Erk2f/f as compared to control in the TA.
Future Directions: Future work will include continuing fiber type analysis on 2A and 2X in STN and TA of the four genotypes
and looking for correlation to observed neuromuscular junction phenotypes (data not shown). The necessity of Erk1/2 signaling
for slow fiber differentiation will be studied in the soleus muscle.
Figure 1: Comparison of fiber area and count between control and Cre+Erk1-/-Erk2f/f in STN.
(A) Area distribution of control and Cre+Erk1-/-Erk2f/f. Measured area from MetaMorph thresholding was grouped into “bins” of 250μm2. Values were normalized by using percentages of the total number of fibers. Both the
control and the Cre+Erk1-/-Erk2f/f have the majority of their fibers fall in the 500-2250μm2 range. However, the control has a second smaller grouping of large fibers in the 2500-3500μm2 range that Cre+Erk1-/-Erk2f/f lacks. In
addition, Cre+Erk1-/-Erk2f/f has more <500μm2 fibers than the control. (B) Average fiber count (±SEM) for controls and Cre+Erk1-/-Erk2f/f. Total fiber counts were obtained from control and Cre+Erk1-/-Erk2f/f animals
(n=3/genotype) during the course of the fiber type analysis. A reduction in total number of fibers can be observed for Cre+Erk1-/-Erk2f/f. The results from the myofiber area distribution, together with the fiber count, account for
the observation that Cre+Erk1-/-Erk2f/f has smaller muscle sections than the controls (Fig 3).
Results, Continued
Results
Figure 3: Myosin and dystrophin fluorescent images.
TA sections for control (A), Erk1-/- (B), Cre+Erk2f/f (C), Cre+Erk1-/-Erk2f/f (D) and
STN sections for control (E), Erk1-/- (F), Cre+Erk2f/f (G), Cre+Erk1-/-Erk2f/f (H)
stained with myosin 2B (green) and dystrophin (red) antibodies, imaged at 10X and
compiled into single images. 2B fibers in both muscles are observed to be larger
than the unstained non-2B fibers, which is consistent with referenced literature
descriptions of fiber types. Scale bar: TA=300μm; STN=200μm. TA sections for
control (I), Erk1-/- (J), Cre+Erk2f/f (K), Cre+Erk1-/-Erk2f/f (L) and STN sections for
control (M), Erk1-/- (N), Cre+Erk2f/f (O), Cre+Erk1-/-Erk2f/f (P) stained with myosin
slow (green) and dystrophin (red) antibodies, imaged at 20X. Slow fibers were
spread throughout the muscle and thus could not be visualized in a single image.
The low number of slow fibers is consistent with fiber composition for these
muscles. Soleus muscle (Q) was used as a staining control, as this muscle has a
large number of slow fibers. Scale bar=100μm.
Figure 4: Quantification of fiber type expression.
Average percentage of fast 2B fiber expression (A) and slow fiber expression (B) in TA and STN was obtained for each of the three animals for each genotype and averaged. 2B comprises roughly half of the total fibers in
both muscles, and no statistical difference was observed within each muscle type. Statistical significance was observed in some of the slow fiber samples. In TA, there is a significant increase in Cre+Erk1-/-Erk2f/f compared to
the control (p=0.007). In the STN, there is a significant decrease in slow fibers in Erk1-/- (p=0.03). Loss of Erk1/2 does not seem to have a major affect on 2B expression, and while there is some impact on slow fibers, these
are such a small portion of the total that it likely does not account for any of the observed phenotypic changes in these animals (data not shown).
0%
2%
4%
6%
8%
10%
12%
14%
16%
PercentFibers
Fiber Area (μm2)
Fiber Area Distribution
Control
Double KO
0
200
400
600
800
1,000
1,200
1,400
1,600
1
TotalNumberofFibers
Genotype
STN Fiber Count
Control
Double KO
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
TA STN
Percent2BFibers
Muscle Type
Fast 2B Fiber Expression
Control
Erk1
Erk2
Double KO
0.00%
0.05%
0.10%
0.15%
0.20%
0.25%
TA STN
PercentSlowFibers
Genotype
Slow Fiber Expression
Control
Erk1
Erk2
Erk Double KO
Figure 2: Animal weights corresponding to age.
Male (A) and female (B) weights for all four
genotypes were taken every week from 4wks through
16wks of age, then taken once every two weeks until
40wks. Little difference is observed between the
controls and Erk1-/-. Cre+Erk2f/f animals were slightly
heavier than the controls, but significance was only
observed in the females at 13, 15, 20, 24, and 28wks
(p=0.004). Cre+Erk1-/-Erk2f/f demonstrates significant
weight difference starting at 6wks for males
(p=0.002) and 10wks for females (p=0.3 at 10wks,
p=0.003 at 11-24wks). Considering the evidence
provided by the area distribution and fiber count,
some of the weight difference observed in Cre+Erk1-/-
Erk2f/f may be attributed to these factors.
10
15
20
25
30
35
40
4 5 6 7 8 9 10 11 12 13 14 15 16 18 20 22 24 26 28 30 32 34 36 38 40
Weight(g)
Age (weeks)
Males
Controls
ERK1 Mutants
ERK2 Mutants
ERK1/2 Mutants
*
10
12
14
16
18
20
22
24
26
28
4 5 6 7 8 9 10 11 12 13 14 15 16 18 20 22 24 26 28 30 32 34 36 38 40
Weight(g)
Age (weeks)
Females
Controls
ERK1 Mutants
ERK2 Mutants
ERK1/2 Mutants
*
*
*
* * *
*
*
A B
C D
E F
G H
I J K
L M N
O P Q
A B
A B
BA
Control
Erk1
Erk2
Erk Double KO
Control
Erk1
Erk2
Erk Double KO
Control
Erk1
Erk2
Erk Double KO
Control
Erk1
Erk2
Erk Double KO
Control
Erk Double KO
Control
Erk Double KO
Control Control
TA Control
STN Control STN Erk1 STN Erk2
STN Double KO
TA Double KO
Double KODouble KO
SOL Control
TA Erk1
TA Erk2
Erk2Erk2
Erk1 Erk1
Supported by NIH grant NS077177 to MR
Schiaffino S and Reggiani C (2011) Fiber types in mammalian skeletal muscles. Physiol Rev 91: 1447-1531.
Purves, Augustine, Fitzpatrick, Hall, LaMantia, and White. Neuroscience. 5th ed. 2012. Print.

More Related Content

What's hot

poster for Bio dept UMB 36x40 rev 5
poster for Bio dept UMB 36x40 rev 5poster for Bio dept UMB 36x40 rev 5
poster for Bio dept UMB 36x40 rev 5Rudy Matheson
 
Epigenetic
EpigeneticEpigenetic
EpigeneticSmawi GH
 
History of Medical Cannabis - Dr. Jahan Marcu
History of Medical Cannabis - Dr. Jahan MarcuHistory of Medical Cannabis - Dr. Jahan Marcu
History of Medical Cannabis - Dr. Jahan MarcuSafeAccess
 
KDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryKDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryChristopher Wynder
 
The Impact of Lysogenic and Tail Assembly Chaperone Proteins on the Life Cycl...
The Impact of Lysogenic and Tail Assembly Chaperone Proteins on the Life Cycl...The Impact of Lysogenic and Tail Assembly Chaperone Proteins on the Life Cycl...
The Impact of Lysogenic and Tail Assembly Chaperone Proteins on the Life Cycl...Wyatt Nelson
 
Zeeuwen 2004-evidence that unrest
Zeeuwen 2004-evidence that unrestZeeuwen 2004-evidence that unrest
Zeeuwen 2004-evidence that unrestdrntcanh
 
Coarse grained molecular dynamic simulation of mammalian mechanosensitive ion...
Coarse grained molecular dynamic simulation of mammalian mechanosensitive ion...Coarse grained molecular dynamic simulation of mammalian mechanosensitive ion...
Coarse grained molecular dynamic simulation of mammalian mechanosensitive ion...Ken Takahashi
 
SURF 2015 Mutagenesis in Ataxia Telangiectasia Induced Pluripotent Stem Cells
SURF 2015 Mutagenesis in Ataxia Telangiectasia Induced Pluripotent Stem CellsSURF 2015 Mutagenesis in Ataxia Telangiectasia Induced Pluripotent Stem Cells
SURF 2015 Mutagenesis in Ataxia Telangiectasia Induced Pluripotent Stem CellsLucy Lin
 
Activity-dependent transcriptional dynamics in mouse primary cortical and hum...
Activity-dependent transcriptional dynamics in mouse primary cortical and hum...Activity-dependent transcriptional dynamics in mouse primary cortical and hum...
Activity-dependent transcriptional dynamics in mouse primary cortical and hum...Darya Vanichkina
 
Duchenne y distrofina_patogenesis_y_oport_de_tto
Duchenne y distrofina_patogenesis_y_oport_de_ttoDuchenne y distrofina_patogenesis_y_oport_de_tto
Duchenne y distrofina_patogenesis_y_oport_de_ttoTamara Jorquiera
 
Rapid glycosylation analysis of mouse serum glycoproteins separated by suppor...
Rapid glycosylation analysis of mouse serum glycoproteins separated by suppor...Rapid glycosylation analysis of mouse serum glycoproteins separated by suppor...
Rapid glycosylation analysis of mouse serum glycoproteins separated by suppor...keilycatalinatavera
 
SfN 2008_Tabata_CruzAguado_Progranulin
SfN 2008_Tabata_CruzAguado_ProgranulinSfN 2008_Tabata_CruzAguado_Progranulin
SfN 2008_Tabata_CruzAguado_ProgranulinPierre Zwiegers
 
Bioinformatic jc 08_14_2013_formal
Bioinformatic jc 08_14_2013_formalBioinformatic jc 08_14_2013_formal
Bioinformatic jc 08_14_2013_formalJennifer Shelton
 
Gerstner et al J Neurosci 2012
Gerstner et al J Neurosci 2012Gerstner et al J Neurosci 2012
Gerstner et al J Neurosci 2012jrgerstn
 
2011 dystroglycan Development Berti-4025-37
2011 dystroglycan Development Berti-4025-372011 dystroglycan Development Berti-4025-37
2011 dystroglycan Development Berti-4025-37Monica Ghidinelli
 

What's hot (20)

poster for Bio dept UMB 36x40 rev 5
poster for Bio dept UMB 36x40 rev 5poster for Bio dept UMB 36x40 rev 5
poster for Bio dept UMB 36x40 rev 5
 
Epigenetic
EpigeneticEpigenetic
Epigenetic
 
History of Medical Cannabis - Dr. Jahan Marcu
History of Medical Cannabis - Dr. Jahan MarcuHistory of Medical Cannabis - Dr. Jahan Marcu
History of Medical Cannabis - Dr. Jahan Marcu
 
članek_Buzar
članek_Buzarčlanek_Buzar
članek_Buzar
 
KDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryKDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discovery
 
The Impact of Lysogenic and Tail Assembly Chaperone Proteins on the Life Cycl...
The Impact of Lysogenic and Tail Assembly Chaperone Proteins on the Life Cycl...The Impact of Lysogenic and Tail Assembly Chaperone Proteins on the Life Cycl...
The Impact of Lysogenic and Tail Assembly Chaperone Proteins on the Life Cycl...
 
Zeeuwen 2004-evidence that unrest
Zeeuwen 2004-evidence that unrestZeeuwen 2004-evidence that unrest
Zeeuwen 2004-evidence that unrest
 
17 ftp
17 ftp17 ftp
17 ftp
 
Coarse grained molecular dynamic simulation of mammalian mechanosensitive ion...
Coarse grained molecular dynamic simulation of mammalian mechanosensitive ion...Coarse grained molecular dynamic simulation of mammalian mechanosensitive ion...
Coarse grained molecular dynamic simulation of mammalian mechanosensitive ion...
 
SURF 2015 Mutagenesis in Ataxia Telangiectasia Induced Pluripotent Stem Cells
SURF 2015 Mutagenesis in Ataxia Telangiectasia Induced Pluripotent Stem CellsSURF 2015 Mutagenesis in Ataxia Telangiectasia Induced Pluripotent Stem Cells
SURF 2015 Mutagenesis in Ataxia Telangiectasia Induced Pluripotent Stem Cells
 
Activity-dependent transcriptional dynamics in mouse primary cortical and hum...
Activity-dependent transcriptional dynamics in mouse primary cortical and hum...Activity-dependent transcriptional dynamics in mouse primary cortical and hum...
Activity-dependent transcriptional dynamics in mouse primary cortical and hum...
 
Duchenne y distrofina_patogenesis_y_oport_de_tto
Duchenne y distrofina_patogenesis_y_oport_de_ttoDuchenne y distrofina_patogenesis_y_oport_de_tto
Duchenne y distrofina_patogenesis_y_oport_de_tto
 
Austin Neurology & Neurosciences
Austin Neurology & NeurosciencesAustin Neurology & Neurosciences
Austin Neurology & Neurosciences
 
Rapid glycosylation analysis of mouse serum glycoproteins separated by suppor...
Rapid glycosylation analysis of mouse serum glycoproteins separated by suppor...Rapid glycosylation analysis of mouse serum glycoproteins separated by suppor...
Rapid glycosylation analysis of mouse serum glycoproteins separated by suppor...
 
SfN 2008_Tabata_CruzAguado_Progranulin
SfN 2008_Tabata_CruzAguado_ProgranulinSfN 2008_Tabata_CruzAguado_Progranulin
SfN 2008_Tabata_CruzAguado_Progranulin
 
Bioinformatic jc 08_14_2013_formal
Bioinformatic jc 08_14_2013_formalBioinformatic jc 08_14_2013_formal
Bioinformatic jc 08_14_2013_formal
 
Gerstner et al J Neurosci 2012
Gerstner et al J Neurosci 2012Gerstner et al J Neurosci 2012
Gerstner et al J Neurosci 2012
 
PurdyPoster2014.1
PurdyPoster2014.1PurdyPoster2014.1
PurdyPoster2014.1
 
2011 dystroglycan Development Berti-4025-37
2011 dystroglycan Development Berti-4025-372011 dystroglycan Development Berti-4025-37
2011 dystroglycan Development Berti-4025-37
 
Definition of epigenetics
Definition of epigeneticsDefinition of epigenetics
Definition of epigenetics
 

Similar to Henslee poster

Kimpo et al_JNsci 2003
Kimpo et al_JNsci 2003Kimpo et al_JNsci 2003
Kimpo et al_JNsci 2003Rhea Kimpo
 
Dr Ayman Ewies - Effect of stretch & Levormeloxifene on the cytoskeleton of c...
Dr Ayman Ewies - Effect of stretch & Levormeloxifene on the cytoskeleton of c...Dr Ayman Ewies - Effect of stretch & Levormeloxifene on the cytoskeleton of c...
Dr Ayman Ewies - Effect of stretch & Levormeloxifene on the cytoskeleton of c...AymanEwies
 
Needle examination [DOC 1 v2].pdf
Needle examination [DOC 1 v2].pdfNeedle examination [DOC 1 v2].pdf
Needle examination [DOC 1 v2].pdfssuserc88386
 
Engineered Ligament Optimization Poster 2014 Updated
Engineered Ligament Optimization Poster 2014 UpdatedEngineered Ligament Optimization Poster 2014 Updated
Engineered Ligament Optimization Poster 2014 UpdatedMichael Selep
 
cell surface actin remodeling
cell surface actin remodelingcell surface actin remodeling
cell surface actin remodelingSoM
 
MLa_URS2015poster
MLa_URS2015posterMLa_URS2015poster
MLa_URS2015posterMichelle La
 
Reversal of neurological defects in a mouse model of rett syndrome
Reversal of neurological defects in a mouse model of rett syndromeReversal of neurological defects in a mouse model of rett syndrome
Reversal of neurological defects in a mouse model of rett syndromeJosé Luis Moreno Garvayo
 
Response Properties of Single Auditory Nerve Fibers in the Mouse
Response Properties of Single Auditory Nerve Fibers in the MouseResponse Properties of Single Auditory Nerve Fibers in the Mouse
Response Properties of Single Auditory Nerve Fibers in the MouseAnnette Taberner-Miller, Ph.D.
 
Epithelial to Mesenchymal Transition Epithelial vs.docx
Epithelial to Mesenchymal Transition Epithelial vs.docxEpithelial to Mesenchymal Transition Epithelial vs.docx
Epithelial to Mesenchymal Transition Epithelial vs.docxSALU18
 
Monitoring neural activities by optical imaging
Monitoring neural activities by optical imagingMonitoring neural activities by optical imaging
Monitoring neural activities by optical imagingMd Kafiul Islam
 
9.15 k1 d parry
9.15 k1 d parry9.15 k1 d parry
9.15 k1 d parryNZIP
 
Biochimica et Biophysica Acta 1860 (2016) 2355–2362Content.docx
Biochimica et Biophysica Acta 1860 (2016) 2355–2362Content.docxBiochimica et Biophysica Acta 1860 (2016) 2355–2362Content.docx
Biochimica et Biophysica Acta 1860 (2016) 2355–2362Content.docxAASTHA76
 
Assessment of a ventral ultrasound-guided suprainguinal approach to block the...
Assessment of a ventral ultrasound-guided suprainguinal approach to block the...Assessment of a ventral ultrasound-guided suprainguinal approach to block the...
Assessment of a ventral ultrasound-guided suprainguinal approach to block the...Diego Fernando Echeverry Bonilla
 
A ‘neural’ net that can be seen with the naked eye - by Andrew Packard
A ‘neural’ net that can be seen with the naked eye - by Andrew PackardA ‘neural’ net that can be seen with the naked eye - by Andrew Packard
A ‘neural’ net that can be seen with the naked eye - by Andrew PackardPim Piepers
 
Tmc gene therapy restores auditory function in deaf mice
Tmc gene therapy restores auditory function in deaf miceTmc gene therapy restores auditory function in deaf mice
Tmc gene therapy restores auditory function in deaf miceJosé Luis Moreno Garvayo
 

Similar to Henslee poster (20)

Kimpo et al_JNsci 2003
Kimpo et al_JNsci 2003Kimpo et al_JNsci 2003
Kimpo et al_JNsci 2003
 
Dr Ayman Ewies - Effect of stretch & Levormeloxifene on the cytoskeleton of c...
Dr Ayman Ewies - Effect of stretch & Levormeloxifene on the cytoskeleton of c...Dr Ayman Ewies - Effect of stretch & Levormeloxifene on the cytoskeleton of c...
Dr Ayman Ewies - Effect of stretch & Levormeloxifene on the cytoskeleton of c...
 
Needle examination [DOC 1 v2].pdf
Needle examination [DOC 1 v2].pdfNeedle examination [DOC 1 v2].pdf
Needle examination [DOC 1 v2].pdf
 
Engineered Ligament Optimization Poster 2014 Updated
Engineered Ligament Optimization Poster 2014 UpdatedEngineered Ligament Optimization Poster 2014 Updated
Engineered Ligament Optimization Poster 2014 Updated
 
cell surface actin remodeling
cell surface actin remodelingcell surface actin remodeling
cell surface actin remodeling
 
MLa_URS2015poster
MLa_URS2015posterMLa_URS2015poster
MLa_URS2015poster
 
Science Pub
Science PubScience Pub
Science Pub
 
Reversal of neurological defects in a mouse model of rett syndrome
Reversal of neurological defects in a mouse model of rett syndromeReversal of neurological defects in a mouse model of rett syndrome
Reversal of neurological defects in a mouse model of rett syndrome
 
Response Properties of Single Auditory Nerve Fibers in the Mouse
Response Properties of Single Auditory Nerve Fibers in the MouseResponse Properties of Single Auditory Nerve Fibers in the Mouse
Response Properties of Single Auditory Nerve Fibers in the Mouse
 
Epithelial to Mesenchymal Transition Epithelial vs.docx
Epithelial to Mesenchymal Transition Epithelial vs.docxEpithelial to Mesenchymal Transition Epithelial vs.docx
Epithelial to Mesenchymal Transition Epithelial vs.docx
 
Monitoring neural activities by optical imaging
Monitoring neural activities by optical imagingMonitoring neural activities by optical imaging
Monitoring neural activities by optical imaging
 
EZH2 Abstract Final
EZH2 Abstract FinalEZH2 Abstract Final
EZH2 Abstract Final
 
swacsm2005abstracts
swacsm2005abstractsswacsm2005abstracts
swacsm2005abstracts
 
9.15 k1 d parry
9.15 k1 d parry9.15 k1 d parry
9.15 k1 d parry
 
Biochimica et Biophysica Acta 1860 (2016) 2355–2362Content.docx
Biochimica et Biophysica Acta 1860 (2016) 2355–2362Content.docxBiochimica et Biophysica Acta 1860 (2016) 2355–2362Content.docx
Biochimica et Biophysica Acta 1860 (2016) 2355–2362Content.docx
 
Assessment of a ventral ultrasound-guided suprainguinal approach to block the...
Assessment of a ventral ultrasound-guided suprainguinal approach to block the...Assessment of a ventral ultrasound-guided suprainguinal approach to block the...
Assessment of a ventral ultrasound-guided suprainguinal approach to block the...
 
J Cell Sci 2005
J Cell Sci 2005J Cell Sci 2005
J Cell Sci 2005
 
A ‘neural’ net that can be seen with the naked eye - by Andrew Packard
A ‘neural’ net that can be seen with the naked eye - by Andrew PackardA ‘neural’ net that can be seen with the naked eye - by Andrew Packard
A ‘neural’ net that can be seen with the naked eye - by Andrew Packard
 
Editing example 1
Editing example 1Editing example 1
Editing example 1
 
Tmc gene therapy restores auditory function in deaf mice
Tmc gene therapy restores auditory function in deaf miceTmc gene therapy restores auditory function in deaf mice
Tmc gene therapy restores auditory function in deaf mice
 

Henslee poster

  • 1. Effect of Erk1/2 on Muscle Fiber Morphology and Differentiation Gabrielle Henslee, Bonnie Seaberg, Ximena Paez, Mendell Rimer Department of Neuroscience & Experimental Therapeutics, Texas A&M Health Science Center College of Medicine, Bryan, TX, USA Materials and Methods Fiber-typing: Sternomastoid (STN) and tibialis anterior (TA) muscles from 14-week-old mice (three animals from each of the four above-mentioned genotypes) were dissected and flash frozen with OCT medium (tissue tek) in an isopentane/liquid N2 bath. 14μm-thick cross-sections were cut in a cryostat and mounted on a slide. Sections were not fixed at any time. Sections were washed in PBS for 5min, then washed three times in PBS-T for 5min each. The cross sections were blocked in PBS-T + 10% normal goat serum for 20min at room temperature and then incubated overnight in a myosin 2B antibody (undiluted, DSHB 10F5) or a myosin slow antibody (undiluted, DSHB A4.840) plus dystrophin (1:300, AbCam 15277). After three 15min washes in PBS-T the following morning, the muscle sections were incubated at room temperature for 2h with a fluorescein- conjugated goat anti-mouse (1:128) and rhodamine-conjugated goat anti-rabbit (1:400) secondary antibody. After washes in PBS-T and PBS, slides were mounted using VectaShield. A 10X, 0.3 NA objective (Nikon Eclipse 1000) was used to acquire widefield images of myofibers with MetaMorph Software, taking as many images needed to encompass the entire area of a single whole muscle section with overlapping myofibers. The images were then compiled into a single picture. Total fibers were counted on the dystrophin channel, and unstained fibers were counted on the color merge. The number and percentage of stained fibers were calculated from these values. Fiber Area: The dystrophin-stained images for control and Cre+Erk1-/-Erk2f/f from the above-described compilations were analyzed for myofiber area using the integrated morphometric analysis tool in MetaMorph. Calibrated images were thresholded for dark objects and manually adjusted to fill the entire interior core surrounded by dystrophin staining for as many myofibers as possible per image. The entire section was analyzed and myofibers overlapped by multiple images were only analyzed a single time. Introduction Fiber Types: Muscle fibers can be classified into two distinct types. Type 1 fibers, also called slow fibers, are characterized by small size and great resistance to fatigue due to rich myoglobin content and mitochondria. Type 1 fibers contract slowly and do not generate much force. Type 2 fibers can be subdivided into three separate categories. Type 2B fibers are generally the largest in size and can generate a great amount of force, but due to low mitochondrial count, they fatigue easily, and thus are also known as fast fatigable units. Type 2A units are an intermediary between slow and 2B. They are not as fast as 2B, generate more force than slow, and are moderately sized. While they fatigue faster than type 1, they have more endurance than 2B. These characteristics have led to them being known as fast fatigue-resistant units. The third type is designated 2X, and its characteristics fall midway between 2A and 2B. Extracellular-signal Regulated Kinase: Extracellular-signal regulated kinase 1 and 2 (Erk1/2) are part of a signaling cascade involved in many different cellular processes. Erk1/2 can act as an inhibitor or an activator during skeletal muscle differentiation. It has also been implicated as playing a role in the regulation of fiber type differentiation. However, literature reports conflicting results regarding the need of Erk1/2 signaling for slow or fast fiber differentiation. Currently no one has fully investigated the effect of Erk1/2 on fiber type distribution in vivo. Hypothesis: Elimination of Erk1/2 (separately and concurrently) will affect muscle fiber morphology and development. Animal Model: The mice used in this study are C57BL/6 background. Erk1 knockouts were generated by inserting a Neo cassette, resulting in germline Erk1 elimination and are noted as Erk1-/-. Erk2 knockouts were generated conditionally making use of the Cre/loxP system. Cre excises sequences flanked by loxP sites; in this way, a gene’s elimination can be controlled by either pharmacologically or constitutively supplying Cre. In this experiment, Cre expression was limited to skeletal muscle fibers by using a human alpha-skeletal actin (HSA) promoter to drive Cre expression. Erk2 conditional knockouts are noted as Cre+Erk2f/f. Control animals were Cre- siblings, as Erk2 expression is unchanged in the absence of Cre. Double knockouts were generated by crossing Erk1-/- and Cre+Erk2f/f animals and backcrossing to reestablish homozygocity. These animals are noted as Cre+Erk1-/-Erk2f/f. Conclusions and Future Studies Area: There is an observed shift in distribution in myofiber area between the control and Cre+Erk1-/-Erk2f/f that, together with total fiber count, likely contributes to both the smaller muscle size and lower observed weights. Fast 2B Fibers: The 2B fiber type comprises 50% or more of the total fibers in both STN and TA for all genotypes and are visually observed to be larger than unstained (non-2B) fibers. No statistical significance was found between the controls and various mutants. Slow Fibers: Neither STN nor TA has many slow fibers. In STN there is a slight reduction in slow fibers in all mutant genotypes as compared to control with significance observed for Erk1-/- only. On the other hand, there is an increase in slow fibers in all mutant genotypes with significance in Cre+Erk1-/-Erk2f/f as compared to control in the TA. Future Directions: Future work will include continuing fiber type analysis on 2A and 2X in STN and TA of the four genotypes and looking for correlation to observed neuromuscular junction phenotypes (data not shown). The necessity of Erk1/2 signaling for slow fiber differentiation will be studied in the soleus muscle. Figure 1: Comparison of fiber area and count between control and Cre+Erk1-/-Erk2f/f in STN. (A) Area distribution of control and Cre+Erk1-/-Erk2f/f. Measured area from MetaMorph thresholding was grouped into “bins” of 250μm2. Values were normalized by using percentages of the total number of fibers. Both the control and the Cre+Erk1-/-Erk2f/f have the majority of their fibers fall in the 500-2250μm2 range. However, the control has a second smaller grouping of large fibers in the 2500-3500μm2 range that Cre+Erk1-/-Erk2f/f lacks. In addition, Cre+Erk1-/-Erk2f/f has more <500μm2 fibers than the control. (B) Average fiber count (±SEM) for controls and Cre+Erk1-/-Erk2f/f. Total fiber counts were obtained from control and Cre+Erk1-/-Erk2f/f animals (n=3/genotype) during the course of the fiber type analysis. A reduction in total number of fibers can be observed for Cre+Erk1-/-Erk2f/f. The results from the myofiber area distribution, together with the fiber count, account for the observation that Cre+Erk1-/-Erk2f/f has smaller muscle sections than the controls (Fig 3). Results, Continued Results Figure 3: Myosin and dystrophin fluorescent images. TA sections for control (A), Erk1-/- (B), Cre+Erk2f/f (C), Cre+Erk1-/-Erk2f/f (D) and STN sections for control (E), Erk1-/- (F), Cre+Erk2f/f (G), Cre+Erk1-/-Erk2f/f (H) stained with myosin 2B (green) and dystrophin (red) antibodies, imaged at 10X and compiled into single images. 2B fibers in both muscles are observed to be larger than the unstained non-2B fibers, which is consistent with referenced literature descriptions of fiber types. Scale bar: TA=300μm; STN=200μm. TA sections for control (I), Erk1-/- (J), Cre+Erk2f/f (K), Cre+Erk1-/-Erk2f/f (L) and STN sections for control (M), Erk1-/- (N), Cre+Erk2f/f (O), Cre+Erk1-/-Erk2f/f (P) stained with myosin slow (green) and dystrophin (red) antibodies, imaged at 20X. Slow fibers were spread throughout the muscle and thus could not be visualized in a single image. The low number of slow fibers is consistent with fiber composition for these muscles. Soleus muscle (Q) was used as a staining control, as this muscle has a large number of slow fibers. Scale bar=100μm. Figure 4: Quantification of fiber type expression. Average percentage of fast 2B fiber expression (A) and slow fiber expression (B) in TA and STN was obtained for each of the three animals for each genotype and averaged. 2B comprises roughly half of the total fibers in both muscles, and no statistical difference was observed within each muscle type. Statistical significance was observed in some of the slow fiber samples. In TA, there is a significant increase in Cre+Erk1-/-Erk2f/f compared to the control (p=0.007). In the STN, there is a significant decrease in slow fibers in Erk1-/- (p=0.03). Loss of Erk1/2 does not seem to have a major affect on 2B expression, and while there is some impact on slow fibers, these are such a small portion of the total that it likely does not account for any of the observed phenotypic changes in these animals (data not shown). 0% 2% 4% 6% 8% 10% 12% 14% 16% PercentFibers Fiber Area (μm2) Fiber Area Distribution Control Double KO 0 200 400 600 800 1,000 1,200 1,400 1,600 1 TotalNumberofFibers Genotype STN Fiber Count Control Double KO 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% TA STN Percent2BFibers Muscle Type Fast 2B Fiber Expression Control Erk1 Erk2 Double KO 0.00% 0.05% 0.10% 0.15% 0.20% 0.25% TA STN PercentSlowFibers Genotype Slow Fiber Expression Control Erk1 Erk2 Erk Double KO Figure 2: Animal weights corresponding to age. Male (A) and female (B) weights for all four genotypes were taken every week from 4wks through 16wks of age, then taken once every two weeks until 40wks. Little difference is observed between the controls and Erk1-/-. Cre+Erk2f/f animals were slightly heavier than the controls, but significance was only observed in the females at 13, 15, 20, 24, and 28wks (p=0.004). Cre+Erk1-/-Erk2f/f demonstrates significant weight difference starting at 6wks for males (p=0.002) and 10wks for females (p=0.3 at 10wks, p=0.003 at 11-24wks). Considering the evidence provided by the area distribution and fiber count, some of the weight difference observed in Cre+Erk1-/- Erk2f/f may be attributed to these factors. 10 15 20 25 30 35 40 4 5 6 7 8 9 10 11 12 13 14 15 16 18 20 22 24 26 28 30 32 34 36 38 40 Weight(g) Age (weeks) Males Controls ERK1 Mutants ERK2 Mutants ERK1/2 Mutants * 10 12 14 16 18 20 22 24 26 28 4 5 6 7 8 9 10 11 12 13 14 15 16 18 20 22 24 26 28 30 32 34 36 38 40 Weight(g) Age (weeks) Females Controls ERK1 Mutants ERK2 Mutants ERK1/2 Mutants * * * * * * * * A B C D E F G H I J K L M N O P Q A B A B BA Control Erk1 Erk2 Erk Double KO Control Erk1 Erk2 Erk Double KO Control Erk1 Erk2 Erk Double KO Control Erk1 Erk2 Erk Double KO Control Erk Double KO Control Erk Double KO Control Control TA Control STN Control STN Erk1 STN Erk2 STN Double KO TA Double KO Double KODouble KO SOL Control TA Erk1 TA Erk2 Erk2Erk2 Erk1 Erk1 Supported by NIH grant NS077177 to MR Schiaffino S and Reggiani C (2011) Fiber types in mammalian skeletal muscles. Physiol Rev 91: 1447-1531. Purves, Augustine, Fitzpatrick, Hall, LaMantia, and White. Neuroscience. 5th ed. 2012. Print.